155 related articles for article (PubMed ID: 19716651)
1. Differential tumor-targeting abilities of three single-domain antibody formats.
Bell A; Wang ZJ; Arbabi-Ghahroudi M; Chang TA; Durocher Y; Trojahn U; Baardsnes J; Jaramillo ML; Li S; Baral TN; O'Connor-McCourt M; Mackenzie R; Zhang J
Cancer Lett; 2010 Mar; 289(1):81-90. PubMed ID: 19716651
[TBL] [Abstract][Full Text] [Related]
2. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
[TBL] [Abstract][Full Text] [Related]
3. Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment.
Baral TN; Murad Y; Nguyen TD; Iqbal U; Zhang J
J Immunol Methods; 2011 Aug; 371(1-2):70-80. PubMed ID: 21741385
[TBL] [Abstract][Full Text] [Related]
4. Isolation of novel EGFR-specific VHH domains.
Gottlin EB; Xiangrong Guan ; Pegram C; Cannedy A; Campa MJ; Patz EF
J Biomol Screen; 2009 Jan; 14(1):77-85. PubMed ID: 19171923
[TBL] [Abstract][Full Text] [Related]
5. Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.
Kettleborough CA; Ansell KH; Allen RW; Rosell-Vives E; Güssow DH; Bendig MM
Eur J Immunol; 1994 Apr; 24(4):952-8. PubMed ID: 8149964
[TBL] [Abstract][Full Text] [Related]
6. Transient expression and purification of chimeric heavy chain antibodies.
Zhang J; Liu X; Bell A; To R; Baral TN; Azizi A; Li J; Cass B; Durocher Y
Protein Expr Purif; 2009 May; 65(1):77-82. PubMed ID: 19007889
[TBL] [Abstract][Full Text] [Related]
7. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
[TBL] [Abstract][Full Text] [Related]
8. Production of chimeric heavy-chain antibodies.
Zhang J; MacKenzie R; Durocher Y
Methods Mol Biol; 2009; 525():323-36, xv. PubMed ID: 19252853
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol.
Doyle PJ; Arbabi-Ghahroudi M; Gaudette N; Furzer G; Savard ME; Gleddie S; McLean MD; Mackenzie CR; Hall JC
Mol Immunol; 2008 Aug; 45(14):3703-13. PubMed ID: 18632156
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
[TBL] [Abstract][Full Text] [Related]
11. Llama single domain antibodies as a tool for molecular mimicry.
Zarebski LM; Urrutia M; Goldbaum FA
J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
13. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
14. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.
Roovers RC; Laeremans T; Huang L; De Taeye S; Verkleij AJ; Revets H; de Haard HJ; van Bergen en Henegouwen PM
Cancer Immunol Immunother; 2007 Mar; 56(3):303-317. PubMed ID: 16738850
[TBL] [Abstract][Full Text] [Related]
17. Development of antiricin single domain antibodies toward detection and therapeutic reagents.
Anderson GP; Liu JL; Hale ML; Bernstein RD; Moore M; Swain MD; Goldman ER
Anal Chem; 2008 Dec; 80(24):9604-11. PubMed ID: 19072267
[TBL] [Abstract][Full Text] [Related]
18. Modulating antibody-dependent cellular cytotoxicity of epidermal growth factor receptor-specific heavy-chain antibodies through hinge engineering.
D'Eall C; Pon RA; Rossotti MA; Krahn N; Spearman M; Callaghan D; van Faassen H; Hussack G; Stetefeld J; Butler M; Durocher Y; Zhang J; Henry KA; Tanha J
Immunol Cell Biol; 2019 Jul; 97(6):526-537. PubMed ID: 30680791
[TBL] [Abstract][Full Text] [Related]
19. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
Afanasieva TA; Wittmer M; Vitaliti A; Ajmo M; Neri D; Klemenz R
Gene Ther; 2003 Oct; 10(21):1850-9. PubMed ID: 12960975
[TBL] [Abstract][Full Text] [Related]
20. Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response.
Li S; Zheng W; Kuolee R; Hirama T; Henry M; Makvandi-Nejad S; Fjällman T; Chen W; Zhang J
Mol Immunol; 2009 May; 46(8-9):1718-26. PubMed ID: 19269688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
